CAI vs HUBB · rev $812.0M vs P/E 28, rev $5.84B
Caris Life Sciences, Inc. Common Stock (CAI) versus Hubbell Inc (HUBB) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Latest reported HUBB revenue for 2025-12-31 was $5.84B. Net income was $887.1M. Revenue was up 3.8% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
CAI currently screens at market cap $5.22B. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Not investment advice. Open the CAI and HUBB stock pages for the full models.
Not investment advice.